XML 70 R43.htm IDEA: XBRL DOCUMENT v3.6.0.2
LONG-TERM DEBT (Tables)
12 Months Ended
Dec. 31, 2016
Debt Disclosure [Abstract]  
Components of Long-Term Debt
 
December 31, 2016
 
December 31, 2015
2016 Term Loan Facility: 2016 Term Loan due 2023, net of discounts and debt issuance costs (see (a) below)
$
1,747.8

 
$

Old Term Loan Facility: Old Acquisition Term Loan due 2019, net of discounts and debt issuance costs (i)

 
662.1

Old Term Loan Facility: 2011 Term Loan due 2017, net of discounts and debt issuance costs (i)

 
658.5

2016 Revolving Credit Facility, due 2021 (see (b) below)

 

6.25% Senior Notes due 2024, net of debt issuance costs (see (c) below)
439.1

 

5.75% Senior Notes due 2021, net of debt issuance costs (see (d) below)
493.8

 
492.5

Spanish Government Loan due 2025  
0.5

 
0.6

 
2,681.2

 
1,813.7

Less current portion (ii)   
(18.1
)
 
(30.0
)
 
$
2,663.1

 
$
1,783.7



(i) The Old Term Loan Facility, which was in place as of December 31, 2015, was comprised of: (i) the term loan due November 19, 2017 in the original aggregate amount of $675.0 million (the "2011 Term Loan"); and (ii) the term loan due October 8, 2019 in the original aggregate amount of $700.0 million (the "Old Acquisition Term Loan") which, respectively, had $651.4 million and $658.6 million in aggregate principal balance outstanding upon their complete refinancing on the September 7, 2016 Elizabeth Arden Acquisition Date (together, the "Old Term Loan Facility" and the "Old Term Loan Agreement," respectively). In connection with the Elizabeth Arden Acquisition and related financing transactions, the Old Term Loan Facility was completely refinanced and terminated on the Elizabeth Arden Acquisition Date. See below for 2016 debt-related transactions.

(ii) At December 31, 2016, the Company classified $18.1 million as the current portion of long-term debt, comprised primarily of $18.0 million of amortization payments on the 2016 Term Loan Facility scheduled to be paid over the next four calendar quarters. At December 31, 2015, the Company classified $30.0 million as the current portion of long-term debt, which was comprised of (a) a $23.2 million required “excess cash flow” prepayment (as defined under the Old Term Loan Agreement, as hereinafter defined) that was paid on February 29, 2016, and (b) the Company’s regularly scheduled $1.7 million quarterly principal amortization payments under the Old Term Loan Facility due in 2016.

Debt Redemption Prices
on
The 5.75% Senior Notes may be redeemed at Products Corporation's option, at any time as a whole, or from time to time in part, at the following redemption prices (expressed as percentages of principal amount), plus accrued interest to the date of redemption, if redeemed during the 12-month period beginning on February 15th of the years indicated below
g). On and after August 1, 2019, Products Corporation may redeem the 6.25% Senior Notes at its option, at any time as a whole, or from time to time in part, at the following redemption prices (expressed as percentages of principal amount), plus accrued interest to (but not including) the date of redemption, if redeemed during the 12-month period beginning on August 1 of the years indicated below
Long-Term Debt Maturities
The aggregate amounts of contractual long-term debt maturities at December 31, 2016 in the years 2017 through 2021 and thereafter are as follows:
Years Ended December 31,
 
Long-Term Debt Maturities
 
2017
 
$
18.1

(a) 
2018
 
18.1

(a) 
2019
 
18.1

(a) 
2020
 
18.1

(a) 
2021
 
518.1

(b) 
Thereafter
 
2,155.5

 
Total long-term debt
 
2,746.0

 
Discounts and deferred finance charges
 
(64.8
)
 
Total long-term debt, net of discounts and deferred finance charges
 
$
2,681.2

 

(a) 
Amount consists primarily of the quarterly amortization payments required under the 2016 Term Loan Facility.
(b) Amount is primarily comprised of the $500.0 million aggregate principal amount outstanding as of December 31, 2016 under the 5.75% Senior Notes, which mature on February 21, 2021, and the quarterly amortization payment described in (a) above.